Name: What doctors don't know about the drugs they prescribe
Uploaded: 2012-09-27T15:01:44Z
Duration: 13 min 12 s
Description: When a new drug gets tested, the results of the trials should be published for the rest of the medical world -- except much of the time, negative or inconclusive findings go unreported, leaving doctors and researchers in the dark. In this impassioned talk, Ben Goldacre explains why these unreported instances of negative data are especially misleading and dangerous.

Raise standards for preclinical cancer research

The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction

Reboxetine for acute treatment of major depression

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

Dissemination and publication of research findings

Neuraminidase inhibitors--the story behind the Cochrane review

From optimism to disillusion about commitment to transparency in the medico-industrial complex

Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials

Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov

When a new drug gets tested, the results of the trials should be published for the rest of the medical world -- except much of the time, negative or inconclusive findings go unreported, leaving doctors and researchers in the dark. In this impassioned talk, Ben Goldacre explains why these unreported instances of negative data are especially misleading and dangerous.

What doctors don't know about the drugs they prescribe

The medical field faces a crisis when negative or inconclusive drug trial results remain unpublished, distorting the evidence that guides treatment. In one striking case, over 100,000 Americans died after being prescribed anti-arrhythmic drugs whose dangers might have been revealed earlier if a failed trial had been shared. On average, half of all medical trials go missing from the public record, making it impossible for doctors and patients to know the true risks and benefits of medicines. Systemic inaction and false fixes perpetuate this problem, threatening public health.